Ozempic While Trying to Conceive: What to Know

If you’re trying to get pregnant and also managing your weight with Ozempic, you’re navigating a genuinely complex situation. The short answer: most providers recommend stopping semaglutide at least two months before actively trying to conceive. But the fuller picture is more nuanced, because weight itself affects fertility, and the reasons you were prescribed Ozempic in the first place don’t disappear when you start trying. Here’s what the current guidance says and how to think through your options.

Why This Question Matters

Obesity and excess weight are directly linked to ovulatory dysfunction, irregular cycles, and reduced IVF success rates. Many women are prescribed GLP-1 medications specifically because their weight is affecting their reproductive health. So stopping Ozempic to try to conceive can feel counterintuitive, particularly when weight loss was part of the fertility plan to begin with.

At the same time, semaglutide has not been studied in pregnant women, and animal studies have shown fetal harm at doses relevant to human use. That’s why Novo Nordisk, the manufacturer, recommends discontinuing Ozempic at least two months before a planned pregnancy. Most reproductive endocrinologists and OBGYNs follow this guidance.

The two-month window isn’t arbitrary. Semaglutide has a half-life of approximately one week, meaning it takes several weeks to clear from the body. The two-month buffer provides a reasonable margin before conception.

What Happens to Fertility While on Ozempic

Here’s something worth knowing: Ozempic can actually improve certain fertility markers before you stop it. For women with insulin resistance or PCOS, semaglutide’s effect on blood sugar regulation and androgen levels can restore more regular ovulation. Some women who had irregular cycles find they normalize during treatment.

This creates an unexpected situation. A woman who assumed she had low fertility due to PCOS may find herself more fertile than expected while on Ozempic, even before stopping. There are documented cases of unintended pregnancies in women on GLP-1 medications, partly because improved metabolic function restored ovulation they didn’t know they had.

The takeaway: don’t assume Ozempic is protective against pregnancy. If you’re sexually active and not ready to conceive yet, use reliable contraception. The birth control and Ozempic article covers an important related point: semaglutide’s effect on gastric emptying may reduce absorption of oral contraceptives, which is worth discussing with your provider.

The Recommended Approach for Women TTC

The general framework most providers follow looks like this:

Step 1: Use Ozempic to reach a healthier weight first. If your BMI is significantly elevated and affecting fertility, losing 10%–15% of body weight before conception can meaningfully improve outcomes. This is often the explicit goal before fertility treatments like IUI or IVF.

Step 2: Stop Ozempic two months before actively trying. This gives the medication time to clear and removes any theoretical fetal exposure risk during early conception.

Step 3: Maintain weight loss through diet and activity during the TTC window. This is the hardest part for most women, because appetite typically returns after stopping GLP-1 medications. Having a structured nutrition plan in place before stopping helps significantly.

Step 4: Reassess after delivery. Many women return to GLP-1 treatment postpartum, once they’ve finished breastfeeding.

Consider this scenario: a 32-year-old woman with PCOS and a BMI of 36 starts compounded semaglutide with the goal of improving her fertility before IVF. Over eight months she loses 28 pounds, her cycles regularize, and her reproductive endocrinologist clears her to proceed. She stops semaglutide two months before her first transfer. That sequence, use the medication strategically then stop before conception, is exactly how many fertility specialists are incorporating GLP-1s into pre-pregnancy care.

What the Research Says

Data specific to semaglutide and human fertility outcomes is still limited, but the broader GLP-1 literature is growing. A 2023 study published in Obesity examined weight loss before assisted reproduction and found that women who lost at least 10% of body weight prior to IVF had significantly higher live birth rates compared to those who did not lose weight beforehand.

For the specific connection between GLP-1 medications and reproductive hormones, GLP-1 for PCOS covers how semaglutide affects androgen levels, insulin, and cycle regularity in detail.

Risks of Continuing Ozempic While Trying to Conceive

The primary concern is fetal exposure during early pregnancy, particularly organogenesis (the period when organs form, roughly weeks 4–10). Because many women don’t know they’re pregnant until after this window, stopping Ozempic before trying eliminates the risk of inadvertent exposure.

Animal studies using semaglutide showed reduced fetal weight and skeletal abnormalities at doses comparable to human therapeutic levels. These findings haven’t been replicated in human studies, partly because pregnant women are excluded from clinical trials, but they’re sufficient to warrant caution.

There’s also a nutritional consideration. Ozempic significantly reduces food intake. Early pregnancy requires adequate caloric and micronutrient intake. A medication that suppresses appetite and slows gastric emptying could theoretically interfere with the nutritional demands of early fetal development.

Talking to Your Provider Before Making Any Changes

Don’t stop Ozempic without a conversation with your prescriber. If you’re working with a fertility specialist, loop them in as well. The timing of stopping, what to do about appetite management during the TTC window, and whether any other medications are appropriate are all decisions that benefit from personalized guidance.

TrimRx providers are available to discuss your situation and help you plan a transition if you’re approaching this stage. You can also explore the semaglutide program to understand what treatment looks like before and after a planned pregnancy pause.

If you’re earlier in the process and still figuring out whether GLP-1 treatment is right for you given your reproductive goals, take the intake assessment to start the conversation with a licensed provider.

The Bottom Line

Ozempic and trying to conceive aren’t necessarily incompatible goals, they just require careful sequencing. Using semaglutide to reach a healthier weight before pregnancy is a legitimate and increasingly common strategy. The key is stopping at least two months before actively trying, maintaining results through lifestyle habits during that window, and working closely with both your prescriber and your reproductive team throughout.

Weight and fertility are deeply connected. Managing one thoughtfully can meaningfully improve the other.

This information is for educational purposes and is not medical advice. Consult with a healthcare provider before starting any medication. Individual results may vary.